Van Andel Institute and Pine Rest researchers have developed biomarkers that appear to accurately predict risk of severe depression during or after pregnancy.
Walmart’s large size and vast resources should cause strategic-minded healthcare leaders to pay attention to moves the retail company is making.
Researchers from the University of Zurich found that a genetic variation present in about 30% of the population can affect how effective peritoneal dialysis is for these patients. Hospital leaders should be aware of this new precision medicine-based discovery.
A new study in Nature Medicine explains how a competition called PANDA (Prostate cANcer graDe Assessment) developed an AI system that can diagnose and grade prostate cancer.
New Study Details How AI Reduces Human Errors When Diagnosing Prostate Cancer Read More »
There is a deficiency of genetic information that includes other ancestry types or mixtures of multiple diverse backgrounds. This new resource may bring hospital leaders closer to equity in precision medicine offerings
Healthcare executives, biotech leaders, and innovators at artificial intelligence companies will gather in San Jose.
New Artificial Intelligence in Healthcare and Diagnostics Conference Debuts in May Read More »
University of Zurich research finds new precision medicine approaches for treating COPD patients helps hospitals reduce 30-day readmission rates.
Researchers are exploring the many diagnostic possibilities of metabolomics. This new Oxford University study demonstrates value in metastatic cancer detection, using a simple blood test.
New Metabolomics Test Developed by Oxford Enables Noninvasive Diagnosis of Cancer Spread Read More »
Hospital, oncology, and pulmonology leaders will benefit from following the research that builds on this innovative study and the treatments that may emerge.
New research shows the promise of repurposing existing drugs for new precision medicine treatments.
